$8.19
0.161.99%
最終更新: Oct 22, 5:50 PM
Benzinga
Benzinga
Benzinga
金曜日, 10 23
Benzinga
© 2026 Benzinga | All Rights Reserved
Market sentiment signals for Xilio Therapeutics (XLO): analyst consensus, short interest, options flow and insider activity.
Analyst Consensus
Outperform
3 analysts
Options Flow (P/C)
—
Avg Consensus PT
$33
+307.0%
Highest Price Target
$56
+583.8%
Lowest Price Target
$16
+95.4%
Short Interest
7.0%
Declining — Bullish
Insider Activity (30d)
—
Short Interest — % of Float
| Date | Firm | Analyst & Accuracy | Upside / Downside | PT Change | Action | Rating |
|---|---|---|---|---|---|---|
| Oct 21, 2026 | Raymond James | Sean McCutcheon— | +95.4% | $16 | Initiate | Outperform |
| Aug 6, 2025 | Leerink Partners | Daina Graybosch— | +241.9% | $28 | Initiate | Outperform |